Asked by: Rachael Maskell (Labour (Co-op) - York Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of (a) stigma and (b) gender norms on trends in the number of men accessing mental health services.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
NHS England’s Advancing Mental Health Equalities Strategy launched in September 2020, to assess inequalities in access, including those based on gender, and to set out guidance on how services should be taking this into account.
Fundamentally, this strategy aims to ensure that access to the timely, high-quality mental healthcare as described in the NHS Long Term Plan is equitable, by equipping systems with the tools and enablers they need to bridge the gaps between people, such as men, faring worse than others in mental health services.
Middle-aged men are identified in Suicide prevention in England: 5-year cross-sector strategy, as a priority group for action. The strategy acknowledges that stigma can be a barrier to people seeking support, and it encourages local government, the National Health Service, and voluntary sector organisations to work together to encourage the reduction of this stigma.
Asked by: John Hayes (Conservative - South Holland and The Deepings)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps she is taking to support unpaid carers in rural areas.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
The Care Act (2014) requires local authorities to deliver a wide range of sustainable, high-quality care and support services, including support for unpaid carers. Local authorities are required to undertake a Carer’s Assessment for any unpaid carer who appears to have a need for support, and to meet their eligible needs on request from the carer.
Through the Accelerating Reform Fund (ARF), we are investing £42.6 million for innovative local projects focused on transforming the care sector. The purpose of the ARF is to support two or more projects in each area, with at least one of those having a particular focus on unpaid carers. More than half of the projects, and at least one in each integrated care system area, are focused on identifying, recognising, and supporting unpaid carers.
Asked by: Dean Russell (Conservative - Watford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent progress NHS England has made on developing a neuropsychiatric service specification.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
NHS England remains committed to the continued development and improvement of all services, including neuropsychiatry. Neuropsychiatry covers a broad spectrum of mental health support, for people with a broad spectrum of neurological conditions, and as such, provision of neuropsychiatry falls within the care pathway of a range of services.
The provision of neuropsychiatry is included in, and will be strengthened within, the updated neurology service specification, neurosurgery specification, and complex rehabilitation service specification. The requirement and scope of a standalone neuropsychiatry service specification is being discussed with the Royal College of Psychiatry and mental health colleagues.
The Neurology Clinical Reference Group (CRG) will continue to lead this work and take forward discussions with the Royal College of Psychiatry, which is represented on both the Neurology CRG and Complex Rehabilitation and Disability CRG, and is contributing to the development of the service specifications listed above.
Asked by: Daisy Cooper (Liberal Democrat - St Albans)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 26 March 2024 to Question 19419 on Infant Mortality: Certification, what her planned timetable is for extending the scheme to pregnancy losses before 1 September 2018.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
On 22 February 2024, we launched the Baby Loss Certificate service, fulfilling our commitment in the Women’s Health Strategy. We recognise that some people will wish to obtain a certificate for a baby loss that happened in the past. It is currently open to pregnancy losses since 1 September 2018, and we will extend this to earlier losses as soon as we can.
Asked by: Rosena Allin-Khan (Labour - Tooting)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many child mental health patients have been held in inappropriate out of area placements since March 2021.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
While NHS England does collect internal management data on this topic, the statistics are not considered robust enough to be published.
Asked by: Rachael Maskell (Labour (Co-op) - York Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if she will amend the NHS Constitution to ensure that rehabilitation is seen as the third pillar of healthcare.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The Government will shortly be consulting on specific changes to the NHS Constitution, in addition to seeking views on the NHS Constitution as a whole. Feedback submitted will be considered during the post-consultation review. The Government will endeavour to issue a response 12 weeks after the consultation has closed.
Asked by: Baroness Jones of Moulsecoomb (Green Party - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what steps they are taking to ensure that the proposed WHO Pandemic Preparedness Treaty, due to be considered by the 77th World Health Assembly in May, will include provisions to improve indoor air quality.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
The United Kingdom welcomes the Pandemic Accord as an opportunity to strengthen global health security. Improving indoor air quality remains an important issue in public health. However, as the Accord aims to establish a high-level framework for pandemic prevention, preparedness and response, we have pursued action on this specific issue in other multilateral settings.
The UK continues to support international improvements to indoor air pollution through its engagement with the World Health Organization (WHO). For example, the UK Health Security Agency (UKHSA) contributed to WHO projects in 2020 and 2022 to assess combined exposure to multiple chemicals in indoor air in schools. UKHSA continues to work with the International Society on Indoor Air Quality and Climate on the development of an open database on international indoor environmental quality guidelines. The database aims to be actively used by researchers, practitioners, and policymakers across the world.
Moreover, the UK was a strong advocate for action to improve indoor air quality at last year’s United Nations General Assembly. We worked with international partners on this issue during the High-Level Meeting on Universal Health Coverage. The UK was supportive of reference being made to the health impacts of indoor air pollution, which was subsequently adopted in the meeting’s political declaration on 5 October 2023, and is available on the United Nations website in an online-only format.
Asked by: Baroness Bennett of Manor Castle (Green Party - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what steps they are taking to ensure minimal usage of helium in MRI scanners in NHS facilities in the light of the global shortage of helium; and what steps they are taking to ensure all helium in scanners being replaced is reused appropriately.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
Suppliers of magnetic resonance imaging (MRI) scanners are moving to a sealed helium solution, whereby the helium required to cool the magnet is approximately 0.5% of the current levels. These sealed systems will also ensure MRI scanners do not require further helium to be added during years of operational use.
Furthermore, suppliers are now replacing MRI scanners without requiring the magnet to be replaced, though this is only available for the first replacement cycle, whereby the scanner is fully replaced, but the existing magnet and helium are retained.
With regards to the Department, as set out in the recent Medical Technology Strategy: One Year On publication, the Design for Life Programme has been stood up to work with industry, the health and care sector, and academic partners to develop medical technology systems that support reuse, remanufacture, and material recovery becoming the default. This includes developing regulatory, commercial, digital, and policy environments that support this aim. The Department’s intention is to publish a roadmap later this year to articulate our relevant findings and plans moving forward.
Asked by: Baroness Goudie (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what steps they are taking to ensure that the NHS is prepared for the arrival of new diagnostic innovations for dementia.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
The National Health Service is a world leader in rolling out innovative treatments and has established a dedicated national programme team which is working in partnership with other national agencies and with local health systems to prepare for the potential roll out of new treatments for use in the earlier stages of Alzheimer’s disease. These plans assume that, if these new treatments are approved by the regulators, significant additional diagnostic capacity, including amyloid positron emission tomography–computed tomography, lumbar puncture and magnetic resonance imaging, will be needed both to identify patients who are most able to benefit and to provide important safety monitoring.
The national programme team is conducting preparations across the country, working alongside clinicians and local teams to identify where further funding will be required to roll out the additional tests and services needed to introduce these new and complex treatments.
NHS England is also working with partner agencies to support and inform further research into other diagnostic modalities, including blood-based biomarker and digital tests, which will help improve identification and management of Alzheimer’s disease.
Asked by: Baroness Ritchie of Downpatrick (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government, with reference to declining immunisation rates in the UK, what level of prioritisation the Department of Health and Social Care and the UK Health Security Agency are giving to the adoption of new immunisation programmes with high uptake.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
The introduction and adoption of new immunisation programmes and achieving high uptake across all immunisation programmes remains a high priority for the Government. We achieve high uptake for both life-course and seasonal vaccinations, with over 90% for pre-school diphtheria, tetanus, and pertussis and among the highest in the world for flu vaccination. The NHS COVID-19 vaccination programme has been the biggest vaccine drive in the history of the National Health Service, implementing the largest volume of new vaccines in the shortest time, and repeatedly with boosters. 157.5 million COVID-19 vaccinations were delivered in England from December 2020 to the end of January 2024. However, over the last decade, performance across routine immunisation programmes has been in decline and continued variation in uptake and coverage between different communities reflects wider health inequalities.
In response to these challenges, the NHS vaccination strategy builds on lessons learnt from the pandemic and the success of our routine immunisation programmes. It aims to maximise uptake and coverage of vaccinations across all communities, improving uptake to save more lives.